Renal Biomarker Market
Renal Biomarker Market Size, Share & Trends Analysis Report By Type (Diagnostic Biomarkers, Prognostic Biomarkers, Predictive Biomarkers, and Pharmacodynamic Biomarkers), by Diagnostic Technique (Elisa, Colorimetric Assay, Liquid Chromatography-Mass Spectrometry, Particle, and Enhanced Turbidimetric Immunoassay), and by End-User (Hospitals, Diagnostic Labs, and Research Centres) Forecast Period (2024-2031)
Renal biomarker market is anticipated to grow at a CAGR of 7.6% during the forecast period (2024-2031). The renal biomarker market is driven by the high prevalence of kidney disease (CKD), the aging population, rising diabetes cases, advancements in diagnostic technologies, and increased awareness about kidney health.
Market Dynamics
Increasing Prevalence of Kidney Diseases
The increasing prevalence of chronic kidney disease (CKD) and acute kidney injury (AKI) is driving the renal biomarker market, with CKD being a leading cause of mortality globally and AKI significantly impacting patient outcomes and healthcare costs. According to the American Kidney Fund (AKF), in June 2024, up to 37 million Americans are affected by kidney disease, with approximately 808,000 living with kidney failure. Over 557,000 individuals are currently receiving dialysis treatment, and in 2021, about 135,000 new cases of kidney failure were diagnosed. Alarmingly, 9 out of 10 individual with kidney disease are unaware of their condition, and 1 in 3 with severely reduced kidney function are additionally unaware they have the disease.
Rising Burden of Diabetes
Renal biomarkers have grown increasingly essential to manage and maintain kidney function owing to the increased incidence of diabetes in low- and middle-income nations. According to the International Diabetes Federation, in 2021, 537 million adults (1 in 10) were living with diabetes, and this number is projected to increase to 643 million by 2030 and 783 million by 2045. Nearly half (44.0%) of adults with diabetes, approximately 240 million, remain undiagnosed, with the majority having type 2 diabetes. More than three-quarters of people with diabetes reside in low and middle-income countries, and 541 million adults are at increased risk of developing type 2 diabetes. Additionally, over 1.2 million children and adolescents (0-19 years old) live with type 1 diabetes. In 2021, diabetes resulted in 6.7 million mortalities and was responsible for at least $966.0 billion in healthcare expenditure, accounting for 9.0% of the global total spent on healthcare.
Market Segmentation
- Based on type, the market is segmented into diagnostic biomarkers, prognostic biomarkers, predictive biomarkers, and pharmacodynamic biomarkers.
- Based on the diagnostic technique, the market is segmented into ELISA, colorimetric assay, liquid chromatography-mass spectrometry, and particle-enhanced turbidimetric immunoassay.
- Based on end-users, the market is segmented into hospitals, diagnostic labs, and research centers.
Diagnostic Biomarkers to Hold a Considerable Market Share
Renal biomarkers, which are essential for the efficient management and treatment of kidney disorders, are in high demand owing to growing public and medical awareness of kidney health and early diagnosis that propels the market growth. Additionally, the favorable government campaigns to diagnose kidney disease is anticipated to offer lucrative opportunities for the growth of this market segment.
Hospital to Hold a Considerable Market Share
Hospitals play an essential role in optimizing critical care resources, aiding in timely clinical decision-making, and improving patient outcomes as primary points of care that propel the market growth. For instance, in October 2021, Baxter and bioMérieux announced the CE Mark for the NEPHROCLEAR CCL14 Test, which aims to predict persistent severe acute kidney injury (PS-AKI). The test, which has a 0.82 AUC, is designed to aid hospitals in optimizing critical care resources and aid in timely clinical decision-making and care pathways.
Regional Outlook
The global renal biomarker market is further segmented based on geography including North America (the US, and Canada), Europe (UK, Italy, Spain, Germany, France, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, and Rest of Asia-Pacific), and the Rest of the World (the Middle East & Africa, and Latin America).
Aging Population Increases The Demand For Healthcare Services In the Asia-Pacific Region
The aging population is predicted to increase healthcare needs globally, including the need for renal biomarkers to effectively manage age-related kidney diseases. According to the International Institute for Population Sciences & United Nations Population Fund, in 2023 over half of all elderly individuals globally live in Asia, where there are 649 million individuals aged 60 and over. The number of elderly individuals can double to 1.3 billion by 2050, accounting for about 25.0% of the globe's population. India, which has 149 million individuals over the age of 60, is predicted to follow accordingly.
Global Renal Biomarker Market Growth by Region 2024-2031
North America Holds Major Market Share
The need for renal biomarkers and other early detection and diagnostic techniques has been driven by the increased awareness of chronic kidney disease in the US, especially among elderly individuals in addition to particular ethnic groups. According to the US Centers for Disease Control and Prevention, in May 2024, the prevalence of chronic kidney diseases is higher among individuals 65 years of age or older (34%) compared to individuals 45–64 years (12%) and 18–44 years (6%). Compared to men(12%), women had a slightly higher prevalence of CKD (14%). Compared to non-Hispanic White adults (12%), non-Hispanic Asian adults (14%), and non-Hispanic Black adults (20%), chronic kidney diseases are more prevalent in the prior group.
Market Players Outlook
*Note: Major Players Sorted in No Particular Order.
The major companies serving the global renal biomarker market include Abbott Laboratories, F. Hoffmann-La Roche Ltd., Randox Laboratories Ltd., Siemens Healthineers, and Thermo Fisher Scientific Inc. among others. The market players are increasingly focusing on business expansion and product development by applying strategies such as collaborations, mergers, and acquisitions to stay competitive in the market. For instance, in March 2024, Aiosyn launched the NephroPath platform, a tool that evaluates histological biomarkers in kidney biopsies. The platform, partnered with Aiosyn, aims to expedite chronic kidney disease therapy development and discover new biomarkers using AI-based quantification.
The Report Covers
- Market value data analysis of 2023 and forecast to 2031.
- Annualized market revenues ($ million) for each market segment.
- Country-wise analysis of major geographical regions.
- Key companies operating in the global renal biomarker market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
- Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
- Analysis of market-entry and market expansion strategies.
- Competitive strategies by identifying ‘who-stands-where’ in the market.
1. Report Summary
• Current Industry Analysis and Growth Potential Outlook
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
1.2.2. By Region
2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Industry Trends
2.2.2. Recommendations
2.2.3. Conclusion
3. Competitive Landscape
3.1. Key Company Analysis
3.2. Abbott Laboratories
3.2.1. Overview
3.2.2. Financial Analysis
3.2.3. SWOT Analysis
3.2.4. Recent Developments
3.3. F. Hoffmann-La Roche Ltd.
3.3.1. Overview
3.3.2. Financial Analysis
3.3.3. SWOT Analysis
3.3.4. Recent Developments
3.4. Randox Laboratories Ltd.
3.4.1. Overview
3.4.2. Financial Analysis
3.4.3. SWOT Analysis
3.4.4. Recent Developments
3.5. Key Strategy Analysis
4. Market Segmentation
4.1. Global Renal Biomarker Market by Type
4.1.1. Diagnostic Biomarkers
4.1.2. Prognostic Biomarkers
4.1.3. Predictive Biomarkers
4.1.4. Pharmacodynamic Biomarkers
4.2. Global Renal Biomarker Market by Diagnostic Technique
4.2.1. Elisa
4.2.2. Colorimetric Assay
4.2.3. Liquid Chromatography-Mass Spectrometry
4.2.4. Particle-Enhanced Turbidimetric Immunoassay
4.3. Global Renal Biomarker Market by End-Users
4.3.1. Hospitals
4.3.2. Diagnostic Labs
4.3.3. Research Centers
5. Regional Analysis
5.1. North America
5.1.1. United States
5.1.2. Canada
5.2. Europe
5.2.1. UK
5.2.2. Germany
5.2.3. Italy
5.2.4. Spain
5.2.5. France
5.2.6. Rest of Europe
5.3. Asia-Pacific
5.3.1. China
5.3.2. India
5.3.3. Japan
5.3.4. South Korea
5.3.5. Rest of Asia-Pacific
5.4. Rest of the World
5.4.1. Latin America
5.4.2. Middle East and Africa
6. Company Profiles
6.1. Astellas Pharma Inc.
6.2. Bayer AG
6.3. Bio Preventive Medicine
6.4. BIOMÉRIEUX
6.5. BioPorto A/S
6.6. Bio-Rad Laboratories, Inc.
6.7. Enzo Biochem Inc.
6.8. Evotec SE
6.9. GE Healthcare Technologies Inc.
6.10. Hytest Ltd.
6.11. Merck Group
6.12. Meso Scale Diagnostics, LLC
6.13. Myriad Genetics, Inc.
6.14. Novartis AG
6.15. Proteomics International
6.16. Quest Diagnostics Inc.
6.17. Siemens Healthineers
6.18. Thermo Fisher Scientific Inc.
1. Global Renal Biomarker Market Research And Analysis By Type, 2023-2031 ($ Million)
2. Global Diagnostic Renal Biomarker Market Research And Analysis By Region, 2023-2031 ($ Million)
3. Global Prognostic Renal Biomarker Market Research And Analysis By Region, 2023-2031 ($ Million)
4. Global Predictive Renal Biomarker Market Research And Analysis By Region, 2023-2031 ($ Million)
5. Global Pharmacodynamic Renal Biomarker Market Research And Analysis By Region, 2023-2031 ($ Million)
6. Global Renal Biomarker Market Research And Analysis By Diagnostic Technique, 2023-2031 ($ Million)
7. Global Elisa Renal Biomarker Market Research And Analysis By Region, 2023-2031 ($ Million)
8. Global Colorimetric Assay Renal Biomarker Market Research And Analysis By Region, 2023-2031 ($ Million)
9. Global Liquid Chromatography-Mass Spectrometry Renal Biomarker Market Research And Analysis By Region, 2023-2031 ($ Million)
10. Global Particle-Enhanced Turbidimetric Immunoassay Renal Biomarker Market Research And Analysis By Region, 2023-2031 ($ Million)
11. Global Renal Biomarker Market Research And Analysis By End-Users, 2023-2031 ($ Million)
12. Global Renal Biomarker For Hospitals Market Research And Analysis By Region, 2023-2031 ($ Million)
13. Global Renal Biomarker For Diagnostic Labs Market Research And Analysis By Region, 2023-2031 ($ Million)
14. Global Renal Biomarker For Research Centers Market Research And Analysis By Region, 2023-2031 ($ Million)
15. Global Renal Biomarker Market Research And Analysis By Region, 2023-2031 ($ Million)
16. North American Renal Biomarker Market Research And Analysis By Country, 2023-2031 ($ Million)
17. North American Renal Biomarker Market Research And Analysis By Type, 2023-2031 ($ Million)
18. North American Renal Biomarker Market Research And Analysis By Diagnostic Technique, 2023-2031 ($ Million)
19. North American Renal Biomarker Market Research And Analysis By End-Users, 2023-2031 ($ Million)
20. European Renal Biomarker Market Research And Analysis By Country, 2023-2031 ($ Million)
21. European Renal Biomarker Market Research And Analysis By Type, 2023-2031 ($ Million)
22. European Renal Biomarker Market Research And Analysis By Diagnostic Technique, 2023-2031 ($ Million)
23. European Renal Biomarker Market Research And Analysis By End-Users, 2023-2031 ($ Million)
24. Asia-Pacific Renal Biomarker Market Research And Analysis By Country, 2023-2031 ($ Million)
25. Asia-Pacific Renal Biomarker Market Research And Analysis By Type, 2023-2031 ($ Million)
26. Asia-Pacific Renal Biomarker Market Research And Analysis By Diagnostic Technique, 2023-2031 ($ Million)
27. Asia-Pacific Renal Biomarker Market Research And Analysis By End-Users, 2023-2031 ($ Million)
28. Rest Of The World Renal Biomarker Market Research And Analysis By Region, 2023-2031 ($ Million)
29. Rest Of The World Renal Biomarker Market Research And Analysis By Type, 2023-2031 ($ Million)
30. Rest Of The World Renal Biomarker Market Research And Analysis By Diagnostic Technique, 2023-2031 ($ Million)
31. Rest Of The World Renal Biomarker Market Research And Analysis By End-Users, 2023-2031 ($ Million)
1. Global Renal Biomarker Market Share By Type, 2023 Vs 2031 (%)
2. Global Diagnostic Renal Biomarker Market Share By Region, 2023 Vs 2031 (%)
3. Global Prognostic Renal Biomarker Market Share By Region, 2023 Vs 2031 (%)
4. Global Predictive Renal Biomarker Market Share By Region, 2023 Vs 2031 (%)
5. Global Pharmacodynamic Renal Biomarker Market Share By Region, 2023 Vs 2031 (%)
6. Global Renal Biomarker Market Share By Diagnostic Technique, 2023 Vs 2031 (%)
7. Global Elisa Renal Biomarker Market Share By Region, 2023 Vs 2031 (%)
8. Global Colorimetric Assay Renal Biomarker Market Share By Region, 2023 Vs 2031 (%)
9. Global Liquid Chromatography-Mass Spectrometry Renal Biomarker Market Share By Region, 2023 Vs 2031 (%)
10. Global Particle-Enhanced Turbidimetric Immunoassay Renal Biomarker Market Share By Region, 2023 Vs 2031 (%)
11. Global Renal Biomarker Market Share By End-Users, 2023 Vs 2031 (%)
12. Global Renal Biomarker For Hospitals Market Share By Region, 2023 Vs 2031 (%)
13. Global Renal Biomarker For Diagnostic Labs Market Share By Region, 2023 Vs 2031 (%)
14. Global Renal Biomarker For Research Centers Market Share By Region, 2023 Vs 2031 (%)
15. Global Renal Biomarker Market Share By Region, 2023 Vs 2031 (%)
16. US Renal Biomarker Market Size, 2023-2031 ($ Million)
17. Canada Renal Biomarker Market Size, 2023-2031 ($ Million)
18. UK Renal Biomarker Market Size, 2023-2031 ($ Million)
19. France Renal Biomarker Market Size, 2023-2031 ($ Million)
20. Germany Renal Biomarker Market Size, 2023-2031 ($ Million)
21. Italy Renal Biomarker Market Size, 2023-2031 ($ Million)
22. Spain Renal Biomarker Market Size, 2023-2031 ($ Million)
23. Rest Of Europe Renal Biomarker Market Size, 2023-2031 ($ Million)
24. India Renal Biomarker Market Size, 2023-2031 ($ Million)
25. China Renal Biomarker Market Size, 2023-2031 ($ Million)
26. Japan Renal Biomarker Market Size, 2023-2031 ($ Million)
27. South Korea Renal Biomarker Market Size, 2023-2031 ($ Million)
28. Rest Of Asia-Pacific Renal Biomarker Market Size, 2023-2031 ($ Million)
29. Latin America Renal Biomarker Market Size, 2023-2031 ($ Million)
30. Middle East And Africa Renal Biomarker Market Size, 2023-2031 ($ Million)
